Gara Jalqabaatti › Cufama Onnee › California › Sacramento
Qorannoo klinikaalii Cufama Onnee Sacramento, CA keessatti
Qorannoo 12 Cufama Onnee f Sacramento fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
HeartShare: Combining Omics, Deep Phenotyping, and Electronic Health Records for Heart Failure Subtypes and Treatment Targets
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
- University of California Davis, Sacramento
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
Namoota walitti qabaa jiraSadarkaa 3
- Sutter Institute for Medical Research (SIMR), Sacramento
- UC Davis Health, Sacramento
Alleviant ALLAY-HFrEF Study
Namoota walitti qabaa jira
- UC Davis Medical Center, Sacramento
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Namoota walitti qabaa jiraSadarkaa 3
- Research Site, Sacramento
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
Namoota walitti qabaa jiraSadarkaa 3
- CON-10024 Sacramento, CA Investigational Site, Sacramento
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
Namoota walitti qabaa jiraSadarkaa 3
- Sacramento, CA Investigative Site 10024, Sacramento
NORM-HF Pivotal Study
Namoota walitti qabaa jira
- UC Davis, Sacramento
LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
Namoota walitti qabaa jiraSadarkaa 3
- Tenax Investigational Site, Sacramento
Alleviant ALLAY-HF Study
Namoota walitti qabaa jira
- UC Davis Medical Center, Sacramento
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists
Namoota walitti qabaa jiraSadarkaa 3
- FIN-10024, Sacramento, CA, Sacramento
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
Namoota walitti qabaa jira
- Sutter Medical Center, Sacramento
Heart Failure Precision Medicine Study
Namoota walitti qabaa jira
- UC Davis Medical Center, Sacramento
Qorannoo Cufama Onnee magaalota biroo keessatti
- New York City, NYQorannoo 51
- Boston, MAQorannoo 44
- Dallas, TXQorannoo 42
- Houston, TXQorannoo 36
- Cleveland, OHQorannoo 33
- Chicago, ILQorannoo 31
- Philadelphia, PAQorannoo 31
- San Francisco, CAQorannoo 29
- St. Louis, MOQorannoo 26
- Durham, NCQorannoo 26
- Atlanta, GAQorannoo 25
- Kansas City, MOQorannoo 25
Qorannoo biroo Sacramento keessatti
- Kansara Qara'a Non-Small CellQorannoo 29
- Dhibee QaraQorannoo 22
- Saree OljooQorannoo 20
- Kansarii ProstateQorannoo 19
- Kansara MetastatikiiQorannoo 16
- Leukemia Myeloidii HamaaQorannoo 12
- Kansarii PancreasQorannoo 12
- Kansarii KoloniiQorannoo 11
- Saree (Gosoota Hunda)Qorannoo 11
- Dukkana BladderQorannoo 10
- Kansarii ColorectalQorannoo 10
- Sukkaraa Gosa 2Qorannoo 9
Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.